<< Mitteilung

2019-10-17 12:00

Nexstim has placed an NBT® System to Epworth Clinic, Australia

Press Release, Helsinki, 17 October 2019 at 1.00pm (EEST)

Nexstim has placed an NBT® System to Epworth Clinic, Australia

Nexstim Plc (NXTMH:HEX, NXTMS:STO) ("Nexstim" or "Company") – the company developing and marketing a unique brain stimulation technology for personalized treatment of major depressive disorder (MDD) – announces that it has placed an NBT® system with SmartFocus® technology to Epworth Clinic in Camberwell, Australia.

Epworth Clinic is known for its world leading mental health research run by Professor Paul Fitzgerald, MD, PhD. Professor Fitzgerald is also in Nexstim’s Scientific Advisory Board, which provides specialist support, advice and guidance to the company as it develops its products and clinical applications.

Professor Fitzgerald and his team will use the system to treat patients with depression and to conduct research in potential new mental health related indications.  

Professor Fitzgerald commented: “Our team is excited to have the NBT® system with SmartFocus® TMS installed. We have been looking forward to using an e-field navigated TMS system with integrated MRI and EMG which enables better targeted and personalized therapy and even developing next generation rTMS protocols.”

Martin Jamieson, CEO of Nexstim Plc, said: “We are delighted that Professor Fitzgerald and his highly skilled team has our NBT® system installed. We believe that their distinguished experience in the field of psychiatry and brain stimulation will have an important role when we constantly develop our navigated TMS technology to better cater to our user clinics and patients.”


Further information is available on the website www.nexstim.com, or by contacting:

Martin Jamieson, Chairman and CEO
+44 771 516 3942
martin.jamieson@nexstim.com


About Nexstim Plc

Nexstim is a Finnish, globally operating medical technology company. Our mission is to enable personalized and effective therapies and diagnostics for challenging brain diseases and disorders.

Nexstim has developed a world-leading non-invasive brain stimulation technology called SmartFocus®. It is a navigated transcranial magnetic stimulation (nTMS) technology with highly sophisticated 3D navigation providing accurate and personalized targeting of the TMS to the specific area of the brain.

SmartFocus® technology is used in Nexstim’s proprietary Navigated Brain Therapy (NBT®) system, which is FDA cleared for marketing and commercial distribution for the treatment of major depressive disorder (MDD) in the United States. In Europe, the NBT® system is CE marked for the treatment of major depression and chronic neuropathic pain.

In addition, Nexstim is commercializing its SmartFocus® based Navigated Brain Stimulation (NBS) system for diagnostic applications. The NBS system is the only FDA cleared and CE marked navigated TMS system for pre-surgical mapping of the speech and motor cortices of the brain. Nexstim shares are listed on the Nasdaq First North Growth Market Finland and Nasdaq First North Growth Market Sweden.

For more information please visit www.nexstim.com

Attachment

Indizes

LU0916829079 673.53 (-0.76%)

Aktien und Anleihen

Aktie Kurs Letz. +/-
Aperam (EUR) 28.12 28.16 -0.14%
ArcelorMittal (EUR) 15.424 15.446 -0.14%
BlueMarHoldings (EUR) 3.7 3.5 +5.71%
Brederode (EUR) 71.6 71.4 +0.28%
EDIFY act. ord. (EUR) 55.0 55.0 +0.00%
HellaGmbHKGaa (EUR) 49.78 49.04 +1.51%
ImmoLux-Airport (EUR) 10.6 11.1 -4.50%
Luxempart (EUR) 53.5 54.5 -1.83%
RTLGroup (EUR) 45.4 45.38 +0.04%
ReinetInvest (EUR) 16.6 16.6 +0.00%
SEO .prvB (EUR) 228.0 240.0 -5.00%
SEO 1/5prvB (EUR) 55.0 51.5 +6.80%
SES FDR (EUR) 16.99 16.875 +0.68%
SocFinCaoutchcs (EUR) 25.0 23.4 +6.84%
Socfinaf (EUR) 11.5 11.4 +0.88%
Socfinasia (EUR) 13.9 13.9 +0.00%
Vonovia (EUR) 45.96 46.56 -1.29%
Anleihe Kurs Letz. +/-
AXA 5,25% 16/04/2040 (EUR) 102.219 102.244 -0.02%
AirbusFinan 2,375% 02/04/2024 (EUR) 109.544 109.584 -0.04%
Astaldi 7,125% 01/12/2020 (EUR) 24.5 24.75 -1.01%
BASF 2,5% 22/01/2024 (EUR) 109.965 109.999 -0.03%
BNGBank 4,375% 16/02/2021 (USD) 103.105 103.126 -0.02%
BarclaysBank 4,75% pp (EUR) 98.981 98.991 -0.01%
Bayer 1,875% 25/01/2021 (EUR) 101.94 101.927 +0.01%
Bayer 2,375% 02/04/2075 (EUR) 101.72 101.745 -0.02%
Bekaert 5% 06/12/2019 (EUR) 100.368 100.347 +0.02%
BenOldmanESB 10% 23/10/2021 (EUR) 102.0 102.0 +0.00%
Bombardier 6,125% 15/05/2021 (EUR) 104.285 104.24 +0.04%
Bouygues 3,625% 16/01/2023 (EUR) 112.186 112.288 -0.09%
CasinoGuichardP FRN pp (EUR) 38.54 37.807 +1.94%
CmaCgm 7,75% 15/01/2021 Reg S (EUR) 89.468 88.983 +0.55%
Colombia 8,375% 15/02/2027 (USD) 119.75 120.25 -0.42%
Daimler 2% 25/06/2021 (EUR) 103.374 103.358 +0.02%
DeutscheBank 2% 02/12/2019 (USD) 96.78 96.75 +0.03%
DeutscheBank 2,2% 17/11/2020 (USD) 98.54 98.56 -0.02%
DtscheLufthansa 5,125% 12/08/2075 (EUR) 105.795 105.855 -0.06%
EFSF 1,875% 23/05/2023 (EUR) 108.01 107.985 +0.02%
EFSF 2,25% 05/09/2022 (EUR) 107.68 107.68 +0.00%
ENI 1,75% 18/01/2024 (EUR) 107.106 107.105 +0.00%
GazCapital 8,625% 28/04/2034 (USD) 143.956 143.876 +0.06%
GiePsaTresor 6% 19/09/2033 (EUR) 145.87 145.52 +0.24%
HeidelbergFinLu 7,5% 03/04/2020 (EUR) 103.0 103.02 -0.02%
HornbachBau 3,875% 15/02/2020 (EUR) 100.938 101.004 -0.07%
KfWA 2% 02/05/2025 (USD) 100.91 101.108 -0.20%
Lafarge 4,75% 23/03/2020 (EUR) 101.773 101.793 -0.02%
Luxembourg 2,125% 10/07/2023 (EUR) 109.59 109.618 -0.03%
Luxembourg 2,25% 19/03/2028 (EUR) 120.127 120.578 -0.37%
Luxembourg 2,25% 21/03/2022 (EUR) 106.886 106.855 +0.03%
Luxembourg 2,75% 20/08/2043 (EUR) 143.669 141.305 +1.67%
Luxembourg 3,375% 18/05/2020 (EUR) 101.995 102.01 -0.01%
MOBY 7,75% 15/02/2023 Reg S (EUR) 35.357 35.574 -0.61%
McDonalds 2% 01/06/2023 (EUR) 107.374 107.405 -0.03%
MüchenerRückGes 6% 26/05/2041 (EUR) 109.108 109.116 -0.01%
NBFinanceLtd FRN 07/02/2035 (EUR) 93.261 93.412 -0.16%
NordRheinWFalen 2,375% 16/09/2021 (USD) 100.961 100.993 -0.03%
NovoBanco 100 09/04/2052 (EUR) 22.992 23.015 -0.10%
NovoBanco 3,5% 02/01/2043 (EUR) 98.858 98.885 -0.03%
OMV 6,25% pp (EUR) 127.625 127.85 -0.18%
Pemex 6,5% 02/06/2041 (USD) 97.839 98.604 -0.78%
PetroVenezuela 12,75% 17/02/2022 (USD) 28.7 27.0 +6.30%
PetroVenezuela 5,375% 12/04/2027 (USD) 13.933 13.933 +0.00%
PetroVenezuela 5,5% 12/04/2037 (USD) 13.93 13.93 +0.00%
Philippines 4,2% 21/01/2024 (USD) 107.915 108.098 -0.17%
Portugal 5,125% 15/10/2024 (USD) 113.035 113.247 -0.19%
RWE 3,5% 21/04/2075 (EUR) 109.995 110.145 -0.14%
RWE 6,625% 30/07/2075 (USD) 113.835 113.745 +0.08%
RaiffeisenBkInt 6% 16/10/2023 (EUR) 120.786 120.831 -0.04%
RussianFed 7,5% 31/03/2030 (USD) 120.594 120.558 +0.03%
SNCFMobilites 4,875% 12/06/2023 (EUR) 118.664 118.78 -0.10%
Sanofi 1,75% 10/09/2026 (EUR) 111.185 111.232 -0.04%
StadaArzneimitt 1,75% 08/04/2022 (EUR) 102.341 102.347 -0.01%
SüdzuckIntlFin FRN pp (EUR) 77.158 76.047 +1.46%
TelecomItaliaCa 7,2% 18/07/2036 (USD) 116.944 116.771 +0.15%
TelecomItaliaFi 7,75% 24/01/2033 (EUR) 148.714 149.131 -0.28%
Thyssenkrupp 2,5% 25/02/2025 (EUR) 103.389 104.06 -0.64%
Turkey 7,375% 05/02/2025 (USD) 108.04 108.049 -0.01%
VWIntlFin 4,625% pp (EUR) 112.04 112.15 -0.10%
VWIntlFin 5,125% pp (EUR) 112.86 113.03 -0.15%
Venezuela 11,75% 21/10/2026 (USD) 17.457 19.685 -11.32%
VeoliaEnvironn 6,125% 25/11/2033 (EUR) 170.286 170.789 -0.29%
YPF 8,5% 28/07/2025 Reg S (USD) 81.338 81.366 -0.03%
ØRSTED A/S 6,25% 26/06/3013 (EUR) 118.5 118.14 +0.30%